Company: PMVP
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001140361-25-015610
Chunk: 53

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 53
---
 $120,000; and |

| • | any of our directors, nominees for director, executive officers or beneficial holders of more than 5% of any class of our outstanding capital stock, or any immediate family member of, or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest. |

Consulting Agreement with Arnold Levine, Ph.D. Arnold Levine, Ph.D., one of our co-founders and a member of our board of directors, serves on our SAB, as well as provides us with additional consulting and advisory services. Dr. Levine receives an annual cash payment of $100,000 for his consulting and advisory services. Scientific Advisory Board - Richard Heyman, Ph.D. Richard Heyman, Ph.D., chairperson of our board of directors, serves on our SAB. Effective as of September 2021, Dr. Heyman waived his rights for any SAB compensation he is otherwise entitled to receive from us for his SAB service. Consulting Agreement with Charles M. Baum, M.D., Ph.D. Charles M. Baum M.D., Ph.D., a member of our board of directors, provides us with additional senior clinical advisory services under a consulting agreement which commenced in February 2024. Dr. Baum receives an annual cash payment of $100,000 for these senior clinical advisory services.

32

TABLE OF CONTENTS

Indemnification of Directors and Officers Our amended and restated certificate of incorporation and amended and restated bylaws provide that we indemnify our directors and officers, and may indemnify our employees and other agents, to the fullest extent permitted by Delaware law. Delaware law prohibits our amended and restated certificate of incorporation from limiting the liability of our directors for the following:

| • | any breach of the director’s duty of loyalty to us or to our stockholders; |

| • | acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; |

| • | unlawful payment of dividends or unlawful stock repurchases or redemptions; and |

| • | any transaction from which the director derived an improper personal benefit. |

If Delaware law is amended to authorize corporate action further eliminating or limiting the personal liability of a director, then the liability of our directors will be eliminated or limited to the fullest extent permitted by Delaware law, as so amended. Our amended and restated certificate of incorporation does not eliminate a director’s duty of care and, in appropriate circumstances, equitable remedies, such as